RNAi’s Buyout Deals: Who Will Benefit?
Apr 17th, 2009 | By Patrick Cox | Category: Financial NewsThere’s been so much stem cell news recently, I haven’t written a lot about the other major breakthrough area in medicine. That is, of course, RNA interference (RNAi). So I’d like to rectify that oversight.